Tech Company Financing Transactions
Onkaido Therapeutics Funding Round
Onkaido Therapeutics, based in Cambridge, secured $20 million from Moderna Therapeutics.
Transaction Overview
Company Name
Announced On
1/17/2014
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
Moderna Therapeutics (Stephane Bancel)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Tech Sq.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
The Onkaido Therapeutics team is exploring how messenger RNA therapeutics can deliver novel oncology drugs to help patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Hoge
Browse more venture capital transactions:
Prev: 1/17/2014: Evocalize venture capital transaction
Next: 1/17/2014: Invisible Sentinel venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC transactions reported here come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs